Resource Propanoic Acid

Predicate	Value (sorted: none)
owl:sameAs	drug:Beta-Alanine
owl:sameAs	drug:L-Glutamic Acid
owl:sameAs	drug:Phylloquinone
drugbank:description	" 79-09-4 experimental James R. Hazen, "Process for production of 3-(hydroxyphenylphosphinyl)-propanoic acid." U.S. Patent US4769182, issued March, 1978. This compound belongs to the polyamines. These are compounds containing more than one amine group. Polyamines Organic Compounds Organonitrogen Compounds Amines Polyamines Enolates Carboxylic Acids logP 0.31 ALOGPS logS 0.68 ALOGPS Water Solubility 3.52e+02 g/l ALOGPS logP 0.48 ChemAxon IUPAC Name propanoic acid ChemAxon Traditional IUPAC Name propanoic acid ChemAxon Molecular Weight 74.0785 ChemAxon Monoisotopic Weight 74.036779436 ChemAxon SMILES CCC(O)=O ChemAxon Molecular Formula C3H6O2 ChemAxon InChI InChI=1S/C3H6O2/c1-2-3(4)5/h2H2,1H3,(H,4,5) ChemAxon InChIKey InChIKey=XBDQKXXYIPTUBI-UHFFFAOYSA-N ChemAxon Polar Surface Area (PSA) 37.3 ChemAxon Refractivity 17.27 ChemAxon Polarizability 7.24 ChemAxon Rotatable Bond Count 1 ChemAxon H Bond Acceptor Count 2 ChemAxon H Bond Donor Count 1 ChemAxon pKa (strongest acidic) 4.75 ChemAxon Physiological Charge -1 ChemAxon Number of Rings 0 ChemAxon Bioavailability 1 ChemAxon Rule of Five true ChemAxon Water Solubility 1E+006 mg/L (at 25 Â°C) US EPA (1981) Melting Point -20.7 Â°C PhysProp Boiling Point 141.1 Â°C PhysProp logP 0.33 HANSCH,C ET AL. (1995) pKa 4.88 SERJEANT,EP & DEMPSEY,B (1979) ChEBI 30768 PubChem Compound 1032 PubChem Substance 46508742 KEGG Compound C00163 KEGG Drug D02310 PDB PPI IUPHAR 1062 Guide to Pharmacology 1062 SMP00201 Methylmalonic Aciduria Due to Cobalamin-Related Disorders DB00121 Biotin DB00142 L-Glutamic Acid DB00161 L-Valine DB03107 Beta-Alanine DB03766 Propanoic Acid DB04524 Malonyl-Coenzyme A Q96PE7 P22033 O95822 Q13085 P24752 Q02252 P80404 P30084 Q6NVY1 P11310 Q9NUB1 Q9H6R3 P05165 P05166 SMP00198 Malonic Aciduria DB00121 Biotin DB00142 L-Glutamic Acid DB00161 L-Valine DB03107 Beta-Alanine DB03766 Propanoic Acid DB04524 Malonyl-Coenzyme A Q96PE7 P22033 O95822 Q13085 P24752 Q02252 P80404 P30084 Q6NVY1 P11310 Q9NUB1 Q9H6R3 P05165 P05166 SMP00502 Malonyl-coa decarboxylase deficiency DB00121 Biotin DB00142 L-Glutamic Acid DB00161 L-Valine DB03107 Beta-Alanine DB03766 Propanoic Acid DB04524 Malonyl-Coenzyme A Q96PE7 P22033 O95822 Q13085 P24752 Q02252 P80404 P30084 Q6NVY1 P11310 Q9NUB1 Q9H6R3 P05165 P05166 SMP00464 Vitamin K Metabolism DB01022 Phylloquinone DB03766 Propanoic Acid P15559 Q9BQB6 P00734 P38435 SMP00016 Propanoate Metabolism DB00121 Biotin DB00142 L-Glutamic Acid DB00161 L-Valine DB03107 Beta-Alanine DB03766 Propanoic Acid DB04524 Malonyl-Coenzyme A Q96PE7 P22033 O95822 Q13085 P24752 Q02252 P80404 P30084 Q6NVY1 P11310 Q9NUB1 Q9H6R3 P05165 P05166 BE0001985 Non-heme chloroperoxidase Pseudomonas fluorescens # Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 # Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423 unknown Non-heme chloroperoxidase Involved in hydrolase activity 2 RH + 2 Cl(-) + H(2)O(2) = 2 RCl + 2 H(2)O cpo Cytoplasmic None 6.03 29652.0 Pseudomonas fluorescens GenBank Gene Database AF031153 GenBank Protein Database 2623869 UniProtKB O31158 UniProt Accession PRXC_PSEFL Chloride peroxidase Chloroperoxidase F CPO-F EC 1.11.1.10 >Non-heme chloroperoxidase MTTFTTRDGTQIYYKDWGSGQPIVFSHGWPLNADSWESQMIFLAAQGYRVIAHDRRGHGR SSQPWSGNDMDTYADDLAQLIEHLDLRDAVLFGFSTGGGEVARYIGRHGTARVAKAGLIS AVPPLMLKTEANPGGLPMEVFDGIRQASLADRSQLYKDLASGPFFGFNQPGAKSSAGMVD WFWLQGMAAGHKNAYDCIKAFSETDFTEDLKKIDVPTLVVHGDADQVVPIEASGIASAAL VKGSTLKIYSGAPHGLTDTHKDQLNADLLAFIKG >825 bp ATGACTACATTCACCACGCGTGACGGCACCCAGATTTATTACAAGGACTGGGGCAGCGGC CAGCCGATTGTCTTCAGCCATGGCTGGCCGCTGAATGCCGACAGTTGGGAGTCGCAGATG ATTTTCCTCGCCGCCCAGGGCTACCGGGTCATCGCTCACGACCGTCGCGGCCATGGCCGC TCCAGCCAGCCGTGGTCCGGCAATGACATGGACACCTATGCCGATGACCTCGCGCAACTG ATCGAACATCTGGATTTGCGCGATGCCGTGCTGTTCGGTTTCTCCACCGGTGGCGGCGAA GTGGCGCGTTACATCGGCCGTCATGGCACCGCCCGCGTGGCCAAGGCCGGGCTGATTTCC GCGGTGCCGCCGCTGATGCTCAAGACCGAAGCCAACCCAGGCGGCCTGCCGATGGAAGTG TTCGACGGCATTCGCCAGGCCTCGCTGGCCGATCGCTCGCAACTGTACAAAGATCTCGCC AGCGGCCCGTTTTTCGGTTTCAACCAGCCCGGCGCGAAATCGTCCGCCGGCATGGTCGAC TGGTTCTGGCTGCAGGGCATGGCCGCCGGCCACAAAAACGCCTACGACTGCATCAAGGCG TTCTCGGAAACCGACTTCACCGAAGACCTGAAGAAAATCGACGTGCCGACGCTGGTGGTG CATGGCGACGCCGACCAGGTAGTGCCGATCGAAGCGTCGGGCATCGCCTCGGCAGCGCTG GTCAAGGGTTCCACGCTGAAGATCTACTCCGGTGCTCCCCATGGCCTGACCGATACCCAT AAAGATCAGCTCAACGCCGACCTGCTGGCGTTCATCAAGGGTTGA PF00561 Abhydrolase_1 function hydrolase activity function catalytic activity process metabolism process cellular metabolism process aromatic compound metabolism process physiological process BE0002652 Gephyrin Human # Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 # Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423 # Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/10592235 unknown Gephyrin Coenzyme transport and metabolism Microtubule-associated protein involved in membrane protein-cytoskeleton interactions. It is thought to anchor the inhibitory glycine receptor (GLYR) to subsynaptic microtubules (By similarity). Involved in molybdenum cofactor biosynthesis. Required for molybdenum transfer to molybdopterin. In a first step, copper-molybdopterin is adenylated. Subsequently, molybdate is inserted into adenylated molybdopterin and AMP is released (By similarity) GPHN 14q23.3 None 5.09 79749.0 Human HUGO Gene Nomenclature Committee (HGNC) HGNC:15465 GenAtlas GPHN GenBank Gene Database AF272663 UniProtKB Q9NQX3 UniProt Accession GEPH_HUMAN >Gephyrin MATEGMILTNHDHQIRVGVLTVSDSCFRNLAEDRSGINLKDLVQDPSLLGGTISAYKIVP DEIEEIKETLIDWCDEKELNLILTTGGTGFAPRDVTPEATKEVIEREAPGMALAMLMGSL NVTPLGMLSRPVCGIRGKTLIINLPGSKKGSQECFQFILPALPHAIDLLRDAIVKVKEVH DELEDLPSPPPPLSPPPTTSPHKQTEDKGVQCEEEEEEKKDSGVASTEDSSSSHITAAAI AAKIPDSIISRGVQVLPRDTASLSTTPSESPRAQATSRLSTASCPTPKVQSRCSSKENIL RASHSAVDITKVARRHRMSPFPLTSMDKAFITVLEMTPVLGTEIINYRDGMGRVLAQDVY AKDNLPPFPASVKDGYAVRAADGPGDRFIIGESQAGEQPTQTVMPGQVMRVTTGAPIPCG ADAVVQVEDTELIRESDDGTEELEVRILVQARPGQDIRPIGHDIKRGECVLAKGTHMGPS EIGLLATVGVTEVEVNKFPVVAVMSTGNELLNPEDDLLPGKIRDSNRSTLLATIQEHGYP TINLGIVGDNPDDLLNALNEGISRADVIITSGGVSMGEKDYLKQVLDIDLHAQIHFGRVF MKPGLPTTFATLDIDGVRKIIFALPGNPVSAVVTCNLFVVPALRKMQGILDPRPTIIKAR LSCDVKLDPRPEYHRCILTWHHQEPLPWAQSTGNQMSSRLMSMRSANGLLMLPPKTEQYV ELHKGEVVDVMVIGRL >2211 bp ATGGCGACCGAGGGAATGATCCTTACTAACCACGACCATCAAATCCGTGTCGGAGTCCTT ACAGTGAGTGATAGTTGCTTCAGGAATCTTGCAGAAGACCGCAGTGGGATAAATCTCAAA GATCTCGTACAAGATCCTTCTTTGTTGGGTGGGACTATATCAGCATACAAGATAGTACCA GATGAAATAGAAGAAATCAAGGAAACCCTGATAGATTGGTGTGATGAAAAGGAACTTAAT TTGATATTAACAACTGGAGGAACAGGATTTGCACCACGAGATGTCACTCCAGAGGCCACA AAAGAAGTAATAGAACGGGAAGCACCAGGGATGGCCCTGGCAATGCTGATGGGATCACTT AATGTTACACCTCTGGGCATGCTCTCTAGGCCTGTATGTGGAATCAGAGGGAAAACGCTC ATAATTAACCTGCCAGGTAGCAAGAAAGGATCTCAGGAATGCTTTCAATTCATACTGCCA GCTCTACCTCATGCCATTGACCTTTTACGTGATGCCATTGTAAAAGTAAAGGAGGTGCAT GATGAACTTGAAGATTTGCCTTCCCCACCTCCCCCTCTTTCCCCTCCTCCTACTACCAGC CCCCATAAACAGACAGAAGACAAAGGAGTTCAATGTGAGGAAGAGGAAGAAGAGAAGAAA GACAGTGGTGTTGCTTCAACAGAAGATAGTTCCTCATCACATATAACTGCAGCAGCCATT GCTGCCAAGATTCCAGACTCCATCATTTCTCGTGGTGTTCAGGTGCTCCCACGAGACACA GCCTCCCTCAGCACTACTCCTTCAGAATCGCCTCGTGCTCAGGCTACATCTCGCCTCTCT ACAGCTTCCTGCCCAACACCAAAAGTCCAGTCCAGGTGCAGCAGCAAGGAGAACATTCTC AGAGCCAGTCACAGTGCTGTCGATATCACCAAGGTGGCTAGAAGACATCGCATGTCTCCT TTTCCTCTGACATCTATGGACAAAGCCTTTATCACAGTCCTGGAGATGACTCCGGTGCTT GGGACAGAAATCATCAATTACCGAGATGGAATGGGGCGAGTCCTTGCTCAAGATGTATAT GCAAAAGACAATTTACCCCCCTTCCCAGCATCAGTAAAAGATGGCTATGCTGTCCGAGCT GCTGATGGCCCAGGAGATCGTTTCATCATTGGGGAATCCCAAGCTGGTGAACAGCCAACT CAGACAGTAATGCCAGGACAAGTCATGCGGGTTACAACAGGTGCTCCAATACCCTGCGGT GCTGATGCAGTAGTACAAGTGGAAGATACCGAACTTATCAGGGAATCAGATGATGGCACT GAAGAACTTGAAGTGCGAATTCTGGTGCAAGCTCGGCCAGGCCAAGATATCAGACCCATC GGCCATGACATTAAAAGAGGGGAATGTGTTTTGGCCAAAGGAACCCACATGGGCCCCTCA GAGATTGGTCTTCTGGCAACTGTAGGTGTCACAGAGGTTGAAGTTAATAAGTTTCCAGTG GTTGCAGTCATGTCAACAGGGAATGAGCTGCTAAATCCTGAAGATGACCTCTTACCAGGG AAGATTCGAGACAGCAATCGTTCAACTCTTCTAGCAACAATTCAGGAACATGGTTACCCC ACGATCAACTTGGGTATTGTAGGAGACAACCCAGATGACTTACTCAATGCCTTGAATGAG GGTATCAGTCGTGCTGATGTCATCATCACATCAGGGGGTGTATCCATGGGGGAAAAGGAC TATCTCAAGCAGGTGCTGGACATTGATCTTCATGCTCAGATCCATTTTGGCAGGGTTTTT ATGAAACCAGGCTTGCCAACAACATTTGCAACTTTGGATATTGATGGTGTAAGAAAAATA ATCTTTGCACTACCTGGGAATCCTGTATCGGCTGTGGTCACCTGCAATCTCTTTGTTGTG CCTGCACTGAGGAAAATGCAGGGCATCTTGGATCCTCGGCCAACCATCATCAAAGCAAGG TTATCATGTGATGTAAAACTTGATCCTCGTCCAGAATACCATCGGTGTATACTAACTTGG CATCACCAAGAACCACTACCTTGGGCACAGAGTACAGGTAATCAAATGAGCAGCCGTCTG ATGAGCATGCGCAGTGCCAATGGATTGTTGATGCTACCTCCAAAGACAGAACAGTACGTG GAGCTCCACAAAGGCGAGGTGGTGGATGTCATGGTCATTGGACGGCTATGA PF00994 MoCF_biosynth PF03454 MoeA_C PF03453 MoeA_N process cellular metabolism process cofactor metabolism process coenzyme metabolism process coenzyme biosynthesis process Mo-molybdopterin cofactor biosynthesis process physiological process process metabolism BE0002742 2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase Pseudomonas fluorescens unknown 2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase Involved in hydrolase activity cumD Cytoplasmic None 5.03 31490.0 Pseudomonas fluorescens GenBank Gene Database D83955 UniProtKB P96965 UniProt Accession P96965_PSEFL >2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase MANLEIGKSILAAGVLTNYHDVGEGQPVILIHGSGPGVSAYANWRLTIPALSKFYRVIAP DMVGFGFTDRPENYNYSKDSWVDHIIGIMDALEIEKAHIVGNSFGGGLAIATALRYSERV DRMVLMGAAGTRFDVTEGLNAVWGYTPSIENMRNLLDIFAYDRSLVTDELARLRYEASIQ PGFQESFSSMFPEPRQRWIDALASSDEDIKTLPNETLIIHGREDQVVPLSSSLRLGELID RAQLHVFGRCGHWTQIEQTDRFNRLVVEFFNEANTPKLVGRP >849 bp ATGGCAAACCTGGAAATAGGTAAAAGTATTTTAGCTGCAGGGGTTCTAACAAACTATCAC GATGTCGGGGAGGGACAGCCTGTGATACTAATTCATGGTTCTGGGCCCGGCGTGAGCGCT TATGCGAATTGGCGACTGACCATTCCTGCTCTGAGCAAGTTTTATCGTGTTATCGCCCCT GATATGGTTGGTTTTGGCTTTACGGATCGACCTGAAAACTATAATTATTCCAAGGATAGT TGGGTTGACCATATAATCGGTATTATGGACGCCCTGGAAATAGAAAAGGCTCACATCGTA GGTAACTCATTCGGTGGGGGGCTGGCGATTGCTACCGCGCTTCGTTATTCGGAGCGCGTT GATCGTATGGTTCTGATGGGGGCGGCCGGTACTCGCTTTGACGTGACAGAGGGCCTGAAC GCGGTGTGGGGTTACACGCCGTCGATAGAAAACATGCGTAATCTCCTCGATATATTCGCT TATGATCGCTCCTTAGTCACCGACGAATTAGCGAGACTTCGATATGAGGCGAGTATTCAG CCAGGATTTCAAGAGTCATTCTCCAGCATGTTTCCTGAGCCGCGCCAACGCTGGATAGAC GCGTTGGCTAGCTCGGATGAAGATATCAAGACTCTTCCCAATGAGACACTGATTATTCAT GGTCGAGAGGATCAGGTTGTTCCTCTATCCAGCAGTCTGCGTCTAGGCGAACTTATCGAC CGGGCGCAGTTGCATGTTTTCGGGCGATGTGGGCACTGGACACAAATTGAGCAGACTGAC CGATTCAATCGTCTTGTGGTCGAGTTTTTTAATGAGGCCAACACACCTAAACTAGTGGGT CGTCCGTAA PF00561 Abhydrolase_1 function hydrolase activity function catalytic activity process metabolism process cellular metabolism process aromatic compound metabolism process physiological process BE0001344 Alanine racemase Geobacillus stearothermophilus # Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 # Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423 unknown Alanine racemase Cell wall/membrane/envelope biogenesis Provides the D-alanine required for cell wall biosynthesis alr None 7.11 43594.0 Geobacillus stearothermophilus GenBank Gene Database M19142 GenBank Protein Database 142467 UniProtKB P10724 UniProt Accession ALR_GEOSE EC 5.1.1.1 >Alanine racemase MNDFHRDTWAEVDLDAIYDNVENLRRLLPDDTHIMAVVKANAYGHGDVQVARTALEAGAS RLAVAFLDEALALREKGIEAPILVLGASRPADAALAAQQRIALTVFRSDWLEEASALYSG PFPIHFHLKMDTGMGRLGVKDEEETKRIVALIERHPHFVLEGLYTHFATADEVNTDYFSY QYTRFLHMLEWLPSRPPLVHCANSAASLRFPDRTFNMVRFGIAMYGLAPSPGIKPLLPYP LKEAFSLHSRLVHVKKLQPGEKVSYGATYTAQTEEWIGTIPIGYADGWLRRLQHFHVLVD GQKAPIVGRICMDQCMIRLPGPLPVGTKVTLIGRQGDEVISIDDVARHLETINYEVPCTI SYRVPRIFFRHKRIMEVRNAIGRGESSA >1161 bp ATGAACGACTTTCATCGCGATACGTGGGCGGAAGTGGATTTGGACGCCATTTACGACAAT GTGGAGAATTTGCGCCGTTTGCTGCCGGACGACACGCACATTATGGCGGTCGTGAAAGCG AACGCCTATGGACATGGGGATGTGCAGGTGGCAAGGACAGCGCTCGAACGGGGGCCTCCG CCTGCGGTTGCCTTTTTGGATGAGGCGCTCGCTTTAAGGGAAAAAGGAATCGAAGCGCCG ATTCTAGTTCTCGGGGCTTCCCGTCCAGCTGATGCGGCGCTGGCCGCCCAGCAGCGCATT GCCCTGACCGTGTTCCGCTCCGACTGGTTGGAAGAAGCGTCCGCCCTTTACAGCGGCCCT TTTCCTATTCATTTCCATTTGAAAATGGACACCGGCATGGGACGGCTTGGAGTGAAAGAC GAGGAAGAGACGAAACGAATCGTAGCGCTGATTGAGCGCCATCCGCATTTTGTGCTTGAA GGGTTGTACACGCATTTTGCGACTGCGGATGAGGTGAACACCGATTATTTTTCCTATCAG TATACCCGTTTTTTGCACATGCTCGAATGGCTGCCGTCGCGCCCGCCGCTCGTCCATTGC GCCAACAGCGCAGCGTCGCTCCGTTTCCCTGACCGGACGTTCAATATGGTCCGCTTCGGC ATTGCCATGTATGGGCTTGCCCCGTCGCCCGGCATCAAGCCGCTGCTGCCGTATCCATTA AAAGAAGCATTTTCGCTCCATAGCCGCCTCGTACACGTCAAAAAACTGCAACCAGGCGAA AAGGTGAGCTATGGTGCGACGTACACTGCGCAGACGGAGGAGTGGATCGGGACGATTCCG ATCGGCTATGCGGACGGCGTCCGCCGCCTGCAGCACTTTCATGTCCTTGTTGACGGACAA AAGGCGCCGATTGTCGGCCGCATTTGCATGGACCAGTGCATGATCCGCCTGCCTGGTCCG CTGCCGGTCGGCACGAAGGTGACACTGATTGGTCGCCAAGGGGACGAGGTAATTTCCATT GATGATGTCGCTCGCCATTTGGAAACGATCAACTACGAAGTGCCTTGCACGATCAGTTAT CGAGTGCCCCGTATTTTTTTCCGCCATAAGCGTATAATGGAAGTGAGAAACGCCATTGGC CGCGGGGAAAGCAGTGCATAA PF00842 Ala_racemase_C PF01168 Ala_racemase_N function vitamin binding function pyridoxal phosphate binding function isomerase activity function racemase and epimerase activity function binding function racemase and epimerase activity, acting on amino acids and derivatives function alanine racemase activity function catalytic activity process amino acid and derivative metabolism process physiological process process pyruvate family amino acid metabolism process metabolism process alanine metabolism process cellular metabolism process amino acid metabolism BE0001194 Fatty acid-binding protein, adipocyte Human # Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 # Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423 # Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/10592235 unknown Fatty acid-binding protein, adipocyte Involved in factty acid binding Lipid transport protein in adipocytes. Binds both long chain fatty acid and retinoic acid FABP4 8q21 Cytoplasm (Potential) None 7.25 14719.0 Human HUGO Gene Nomenclature Committee (HGNC) HGNC:3559 GenAtlas FABP4 GeneCards FABP4 GenBank Gene Database J02874 GenBank Protein Database 178347 UniProtKB P15090 UniProt Accession FABP4_HUMAN A-FABP Adipocyte lipid-binding protein AFABP ALBP >Fatty acid-binding protein, adipocyte MCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKN TEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVM KGVTSTRVYERA >399 bp ATGTGTGATGCTTTTGTAGGTACCTGGAAACTTGTCTCCAGTGAAAACTTTGATGATTAT ATGAAAGAAGTAGGAGTGGGCTTTGCCACCAGGAAAGTGGCTGGCATGGCCAAACCTAAC ATGATCATCAGTGTGAATGGGGATGTGATCACCATTAAATCTGAAAGTACCTTTAAAAAT ACTGAGATTTCCTTCATACTGGGCCAGGAATTTGACGAAGTCACTGCAGATGACAGGAAA GTCAAGAGCACCATAACCTTAGATGGGGGTGTCCTGGTACATGTGCAGAAATGGGATGGA AAATCAACCACCATAAAGAGAAAACGAGAGGATGATAAACTGGTGGTGGAATGCGTCATG AAAGGCGTCACTTCCACGAGAGTTTATGAGAGAGCATAA PF00061 Lipocalin function lipid binding function binding process cellular physiological process process transport process physiological process "
owl:sameAs	drug:Propanoic Acid
owl:sameAs	drug:Biotin
owl:sameAs	drug:L-Valine
owl:sameAs	drug:Malonyl-Coenzyme A
rdfs:label	"Propanoic Acid"
rdf:type	drugbank:drugs
owl:sameAs	drug:EXPT02641

" 79-09-4 experimental James R. Hazen, "Process for production of 3-(hydroxyphenylphosphinyl)-propanoic acid." U.S. Patent US4769182, issued March, 1978. This compound belongs to the polyamines. These are compounds containing more than one amine group. Polyamines Organic Compounds Organonitrogen Compounds Amines Polyamines Enolates Carboxylic Acids logP 0.31 ALOGPS logS 0.68 ALOGPS Water Solubility 3.52e+02 g/l ALOGPS logP 0.48 ChemAxon IUPAC Name propanoic acid ChemAxon Traditional IUPAC Name propanoic acid ChemAxon Molecular Weight 74.0785 ChemAxon Monoisotopic Weight 74.036779436 ChemAxon SMILES CCC(O)=O ChemAxon Molecular Formula C3H6O2 ChemAxon InChI InChI=1S/C3H6O2/c1-2-3(4)5/h2H2,1H3,(H,4,5) ChemAxon InChIKey InChIKey=XBDQKXXYIPTUBI-UHFFFAOYSA-N ChemAxon Polar Surface Area (PSA) 37.3 ChemAxon Refractivity 17.27 ChemAxon Polarizability 7.24 ChemAxon Rotatable Bond Count 1 ChemAxon H Bond Acceptor Count 2 ChemAxon H Bond Donor Count 1 ChemAxon pKa (strongest acidic) 4.75 ChemAxon Physiological Charge -1 ChemAxon Number of Rings 0 ChemAxon Bioavailability 1 ChemAxon Rule of Five true ChemAxon Water Solubility 1E+006 mg/L (at 25 Â°C) US EPA (1981) Melting Point -20.7 Â°C PhysProp Boiling Point 141.1 Â°C PhysProp logP 0.33 HANSCH,C ET AL. (1995) pKa 4.88 SERJEANT,EP & DEMPSEY,B (1979) ChEBI 30768 PubChem Compound 1032 PubChem Substance 46508742 KEGG Compound C00163 KEGG Drug D02310 PDB PPI IUPHAR 1062 Guide to Pharmacology 1062 SMP00201 Methylmalonic Aciduria Due to Cobalamin-Related Disorders DB00121 Biotin DB00142 L-Glutamic Acid DB00161 L-Valine DB03107 Beta-Alanine DB03766 Propanoic Acid DB04524 Malonyl-Coenzyme A Q96PE7 P22033 O95822 Q13085 P24752 Q02252 P80404 P30084 Q6NVY1 P11310 Q9NUB1 Q9H6R3 P05165 P05166 SMP00198 Malonic Aciduria DB00121 Biotin DB00142 L-Glutamic Acid DB00161 L-Valine DB03107 Beta-Alanine DB03766 Propanoic Acid DB04524 Malonyl-Coenzyme A Q96PE7 P22033 O95822 Q13085 P24752 Q02252 P80404 P30084 Q6NVY1 P11310 Q9NUB1 Q9H6R3 P05165 P05166 SMP00502 Malonyl-coa decarboxylase deficiency DB00121 Biotin DB00142 L-Glutamic Acid DB00161 L-Valine DB03107 Beta-Alanine DB03766 Propanoic Acid DB04524 Malonyl-Coenzyme A Q96PE7 P22033 O95822 Q13085 P24752 Q02252 P80404 P30084 Q6NVY1 P11310 Q9NUB1 Q9H6R3 P05165 P05166 SMP00464 Vitamin K Metabolism DB01022 Phylloquinone DB03766 Propanoic Acid P15559 Q9BQB6 P00734 P38435 SMP00016 Propanoate Metabolism DB00121 Biotin DB00142 L-Glutamic Acid DB00161 L-Valine DB03107 Beta-Alanine DB03766 Propanoic Acid DB04524 Malonyl-Coenzyme A Q96PE7 P22033 O95822 Q13085 P24752 Q02252 P80404 P30084 Q6NVY1 P11310 Q9NUB1 Q9H6R3 P05165 P05166 BE0001985 Non-heme chloroperoxidase Pseudomonas fluorescens # Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 # Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423 unknown Non-heme chloroperoxidase Involved in hydrolase activity 2 RH + 2 Cl(-) + H(2)O(2) = 2 RCl + 2 H(2)O cpo Cytoplasmic None 6.03 29652.0 Pseudomonas fluorescens GenBank Gene Database AF031153 GenBank Protein Database 2623869 UniProtKB O31158 UniProt Accession PRXC_PSEFL Chloride peroxidase Chloroperoxidase F CPO-F EC 1.11.1.10 >Non-heme chloroperoxidase MTTFTTRDGTQIYYKDWGSGQPIVFSHGWPLNADSWESQMIFLAAQGYRVIAHDRRGHGR SSQPWSGNDMDTYADDLAQLIEHLDLRDAVLFGFSTGGGEVARYIGRHGTARVAKAGLIS AVPPLMLKTEANPGGLPMEVFDGIRQASLADRSQLYKDLASGPFFGFNQPGAKSSAGMVD WFWLQGMAAGHKNAYDCIKAFSETDFTEDLKKIDVPTLVVHGDADQVVPIEASGIASAAL VKGSTLKIYSGAPHGLTDTHKDQLNADLLAFIKG >825 bp ATGACTACATTCACCACGCGTGACGGCACCCAGATTTATTACAAGGACTGGGGCAGCGGC CAGCCGATTGTCTTCAGCCATGGCTGGCCGCTGAATGCCGACAGTTGGGAGTCGCAGATG ATTTTCCTCGCCGCCCAGGGCTACCGGGTCATCGCTCACGACCGTCGCGGCCATGGCCGC TCCAGCCAGCCGTGGTCCGGCAATGACATGGACACCTATGCCGATGACCTCGCGCAACTG ATCGAACATCTGGATTTGCGCGATGCCGTGCTGTTCGGTTTCTCCACCGGTGGCGGCGAA GTGGCGCGTTACATCGGCCGTCATGGCACCGCCCGCGTGGCCAAGGCCGGGCTGATTTCC GCGGTGCCGCCGCTGATGCTCAAGACCGAAGCCAACCCAGGCGGCCTGCCGATGGAAGTG TTCGACGGCATTCGCCAGGCCTCGCTGGCCGATCGCTCGCAACTGTACAAAGATCTCGCC AGCGGCCCGTTTTTCGGTTTCAACCAGCCCGGCGCGAAATCGTCCGCCGGCATGGTCGAC TGGTTCTGGCTGCAGGGCATGGCCGCCGGCCACAAAAACGCCTACGACTGCATCAAGGCG TTCTCGGAAACCGACTTCACCGAAGACCTGAAGAAAATCGACGTGCCGACGCTGGTGGTG CATGGCGACGCCGACCAGGTAGTGCCGATCGAAGCGTCGGGCATCGCCTCGGCAGCGCTG GTCAAGGGTTCCACGCTGAAGATCTACTCCGGTGCTCCCCATGGCCTGACCGATACCCAT AAAGATCAGCTCAACGCCGACCTGCTGGCGTTCATCAAGGGTTGA PF00561 Abhydrolase_1 function hydrolase activity function catalytic activity process metabolism process cellular metabolism process aromatic compound metabolism process physiological process BE0002652 Gephyrin Human # Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 # Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423 # Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/10592235 unknown Gephyrin Coenzyme transport and metabolism Microtubule-associated protein involved in membrane protein-cytoskeleton interactions. It is thought to anchor the inhibitory glycine receptor (GLYR) to subsynaptic microtubules (By similarity). Involved in molybdenum cofactor biosynthesis. Required for molybdenum transfer to molybdopterin. In a first step, copper-molybdopterin is adenylated. Subsequently, molybdate is inserted into adenylated molybdopterin and AMP is released (By similarity) GPHN 14q23.3 None 5.09 79749.0 Human HUGO Gene Nomenclature Committee (HGNC) HGNC:15465 GenAtlas GPHN GenBank Gene Database AF272663 UniProtKB Q9NQX3 UniProt Accession GEPH_HUMAN >Gephyrin MATEGMILTNHDHQIRVGVLTVSDSCFRNLAEDRSGINLKDLVQDPSLLGGTISAYKIVP DEIEEIKETLIDWCDEKELNLILTTGGTGFAPRDVTPEATKEVIEREAPGMALAMLMGSL NVTPLGMLSRPVCGIRGKTLIINLPGSKKGSQECFQFILPALPHAIDLLRDAIVKVKEVH DELEDLPSPPPPLSPPPTTSPHKQTEDKGVQCEEEEEEKKDSGVASTEDSSSSHITAAAI AAKIPDSIISRGVQVLPRDTASLSTTPSESPRAQATSRLSTASCPTPKVQSRCSSKENIL RASHSAVDITKVARRHRMSPFPLTSMDKAFITVLEMTPVLGTEIINYRDGMGRVLAQDVY AKDNLPPFPASVKDGYAVRAADGPGDRFIIGESQAGEQPTQTVMPGQVMRVTTGAPIPCG ADAVVQVEDTELIRESDDGTEELEVRILVQARPGQDIRPIGHDIKRGECVLAKGTHMGPS EIGLLATVGVTEVEVNKFPVVAVMSTGNELLNPEDDLLPGKIRDSNRSTLLATIQEHGYP TINLGIVGDNPDDLLNALNEGISRADVIITSGGVSMGEKDYLKQVLDIDLHAQIHFGRVF MKPGLPTTFATLDIDGVRKIIFALPGNPVSAVVTCNLFVVPALRKMQGILDPRPTIIKAR LSCDVKLDPRPEYHRCILTWHHQEPLPWAQSTGNQMSSRLMSMRSANGLLMLPPKTEQYV ELHKGEVVDVMVIGRL >2211 bp ATGGCGACCGAGGGAATGATCCTTACTAACCACGACCATCAAATCCGTGTCGGAGTCCTT ACAGTGAGTGATAGTTGCTTCAGGAATCTTGCAGAAGACCGCAGTGGGATAAATCTCAAA GATCTCGTACAAGATCCTTCTTTGTTGGGTGGGACTATATCAGCATACAAGATAGTACCA GATGAAATAGAAGAAATCAAGGAAACCCTGATAGATTGGTGTGATGAAAAGGAACTTAAT TTGATATTAACAACTGGAGGAACAGGATTTGCACCACGAGATGTCACTCCAGAGGCCACA AAAGAAGTAATAGAACGGGAAGCACCAGGGATGGCCCTGGCAATGCTGATGGGATCACTT AATGTTACACCTCTGGGCATGCTCTCTAGGCCTGTATGTGGAATCAGAGGGAAAACGCTC ATAATTAACCTGCCAGGTAGCAAGAAAGGATCTCAGGAATGCTTTCAATTCATACTGCCA GCTCTACCTCATGCCATTGACCTTTTACGTGATGCCATTGTAAAAGTAAAGGAGGTGCAT GATGAACTTGAAGATTTGCCTTCCCCACCTCCCCCTCTTTCCCCTCCTCCTACTACCAGC CCCCATAAACAGACAGAAGACAAAGGAGTTCAATGTGAGGAAGAGGAAGAAGAGAAGAAA GACAGTGGTGTTGCTTCAACAGAAGATAGTTCCTCATCACATATAACTGCAGCAGCCATT GCTGCCAAGATTCCAGACTCCATCATTTCTCGTGGTGTTCAGGTGCTCCCACGAGACACA GCCTCCCTCAGCACTACTCCTTCAGAATCGCCTCGTGCTCAGGCTACATCTCGCCTCTCT ACAGCTTCCTGCCCAACACCAAAAGTCCAGTCCAGGTGCAGCAGCAAGGAGAACATTCTC AGAGCCAGTCACAGTGCTGTCGATATCACCAAGGTGGCTAGAAGACATCGCATGTCTCCT TTTCCTCTGACATCTATGGACAAAGCCTTTATCACAGTCCTGGAGATGACTCCGGTGCTT GGGACAGAAATCATCAATTACCGAGATGGAATGGGGCGAGTCCTTGCTCAAGATGTATAT GCAAAAGACAATTTACCCCCCTTCCCAGCATCAGTAAAAGATGGCTATGCTGTCCGAGCT GCTGATGGCCCAGGAGATCGTTTCATCATTGGGGAATCCCAAGCTGGTGAACAGCCAACT CAGACAGTAATGCCAGGACAAGTCATGCGGGTTACAACAGGTGCTCCAATACCCTGCGGT GCTGATGCAGTAGTACAAGTGGAAGATACCGAACTTATCAGGGAATCAGATGATGGCACT GAAGAACTTGAAGTGCGAATTCTGGTGCAAGCTCGGCCAGGCCAAGATATCAGACCCATC GGCCATGACATTAAAAGAGGGGAATGTGTTTTGGCCAAAGGAACCCACATGGGCCCCTCA GAGATTGGTCTTCTGGCAACTGTAGGTGTCACAGAGGTTGAAGTTAATAAGTTTCCAGTG GTTGCAGTCATGTCAACAGGGAATGAGCTGCTAAATCCTGAAGATGACCTCTTACCAGGG AAGATTCGAGACAGCAATCGTTCAACTCTTCTAGCAACAATTCAGGAACATGGTTACCCC ACGATCAACTTGGGTATTGTAGGAGACAACCCAGATGACTTACTCAATGCCTTGAATGAG GGTATCAGTCGTGCTGATGTCATCATCACATCAGGGGGTGTATCCATGGGGGAAAAGGAC TATCTCAAGCAGGTGCTGGACATTGATCTTCATGCTCAGATCCATTTTGGCAGGGTTTTT ATGAAACCAGGCTTGCCAACAACATTTGCAACTTTGGATATTGATGGTGTAAGAAAAATA ATCTTTGCACTACCTGGGAATCCTGTATCGGCTGTGGTCACCTGCAATCTCTTTGTTGTG CCTGCACTGAGGAAAATGCAGGGCATCTTGGATCCTCGGCCAACCATCATCAAAGCAAGG TTATCATGTGATGTAAAACTTGATCCTCGTCCAGAATACCATCGGTGTATACTAACTTGG CATCACCAAGAACCACTACCTTGGGCACAGAGTACAGGTAATCAAATGAGCAGCCGTCTG ATGAGCATGCGCAGTGCCAATGGATTGTTGATGCTACCTCCAAAGACAGAACAGTACGTG GAGCTCCACAAAGGCGAGGTGGTGGATGTCATGGTCATTGGACGGCTATGA PF00994 MoCF_biosynth PF03454 MoeA_C PF03453 MoeA_N process cellular metabolism process cofactor metabolism process coenzyme metabolism process coenzyme biosynthesis process Mo-molybdopterin cofactor biosynthesis process physiological process process metabolism BE0002742 2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase Pseudomonas fluorescens unknown 2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase Involved in hydrolase activity cumD Cytoplasmic None 5.03 31490.0 Pseudomonas fluorescens GenBank Gene Database D83955 UniProtKB P96965 UniProt Accession P96965_PSEFL >2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase MANLEIGKSILAAGVLTNYHDVGEGQPVILIHGSGPGVSAYANWRLTIPALSKFYRVIAP DMVGFGFTDRPENYNYSKDSWVDHIIGIMDALEIEKAHIVGNSFGGGLAIATALRYSERV DRMVLMGAAGTRFDVTEGLNAVWGYTPSIENMRNLLDIFAYDRSLVTDELARLRYEASIQ PGFQESFSSMFPEPRQRWIDALASSDEDIKTLPNETLIIHGREDQVVPLSSSLRLGELID RAQLHVFGRCGHWTQIEQTDRFNRLVVEFFNEANTPKLVGRP >849 bp ATGGCAAACCTGGAAATAGGTAAAAGTATTTTAGCTGCAGGGGTTCTAACAAACTATCAC GATGTCGGGGAGGGACAGCCTGTGATACTAATTCATGGTTCTGGGCCCGGCGTGAGCGCT TATGCGAATTGGCGACTGACCATTCCTGCTCTGAGCAAGTTTTATCGTGTTATCGCCCCT GATATGGTTGGTTTTGGCTTTACGGATCGACCTGAAAACTATAATTATTCCAAGGATAGT TGGGTTGACCATATAATCGGTATTATGGACGCCCTGGAAATAGAAAAGGCTCACATCGTA GGTAACTCATTCGGTGGGGGGCTGGCGATTGCTACCGCGCTTCGTTATTCGGAGCGCGTT GATCGTATGGTTCTGATGGGGGCGGCCGGTACTCGCTTTGACGTGACAGAGGGCCTGAAC GCGGTGTGGGGTTACACGCCGTCGATAGAAAACATGCGTAATCTCCTCGATATATTCGCT TATGATCGCTCCTTAGTCACCGACGAATTAGCGAGACTTCGATATGAGGCGAGTATTCAG CCAGGATTTCAAGAGTCATTCTCCAGCATGTTTCCTGAGCCGCGCCAACGCTGGATAGAC GCGTTGGCTAGCTCGGATGAAGATATCAAGACTCTTCCCAATGAGACACTGATTATTCAT GGTCGAGAGGATCAGGTTGTTCCTCTATCCAGCAGTCTGCGTCTAGGCGAACTTATCGAC CGGGCGCAGTTGCATGTTTTCGGGCGATGTGGGCACTGGACACAAATTGAGCAGACTGAC CGATTCAATCGTCTTGTGGTCGAGTTTTTTAATGAGGCCAACACACCTAAACTAGTGGGT CGTCCGTAA PF00561 Abhydrolase_1 function hydrolase activity function catalytic activity process metabolism process cellular metabolism process aromatic compound metabolism process physiological process BE0001344 Alanine racemase Geobacillus stearothermophilus # Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 # Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423 unknown Alanine racemase Cell wall/membrane/envelope biogenesis Provides the D-alanine required for cell wall biosynthesis alr None 7.11 43594.0 Geobacillus stearothermophilus GenBank Gene Database M19142 GenBank Protein Database 142467 UniProtKB P10724 UniProt Accession ALR_GEOSE EC 5.1.1.1 >Alanine racemase MNDFHRDTWAEVDLDAIYDNVENLRRLLPDDTHIMAVVKANAYGHGDVQVARTALEAGAS RLAVAFLDEALALREKGIEAPILVLGASRPADAALAAQQRIALTVFRSDWLEEASALYSG PFPIHFHLKMDTGMGRLGVKDEEETKRIVALIERHPHFVLEGLYTHFATADEVNTDYFSY QYTRFLHMLEWLPSRPPLVHCANSAASLRFPDRTFNMVRFGIAMYGLAPSPGIKPLLPYP LKEAFSLHSRLVHVKKLQPGEKVSYGATYTAQTEEWIGTIPIGYADGWLRRLQHFHVLVD GQKAPIVGRICMDQCMIRLPGPLPVGTKVTLIGRQGDEVISIDDVARHLETINYEVPCTI SYRVPRIFFRHKRIMEVRNAIGRGESSA >1161 bp ATGAACGACTTTCATCGCGATACGTGGGCGGAAGTGGATTTGGACGCCATTTACGACAAT GTGGAGAATTTGCGCCGTTTGCTGCCGGACGACACGCACATTATGGCGGTCGTGAAAGCG AACGCCTATGGACATGGGGATGTGCAGGTGGCAAGGACAGCGCTCGAACGGGGGCCTCCG CCTGCGGTTGCCTTTTTGGATGAGGCGCTCGCTTTAAGGGAAAAAGGAATCGAAGCGCCG ATTCTAGTTCTCGGGGCTTCCCGTCCAGCTGATGCGGCGCTGGCCGCCCAGCAGCGCATT GCCCTGACCGTGTTCCGCTCCGACTGGTTGGAAGAAGCGTCCGCCCTTTACAGCGGCCCT TTTCCTATTCATTTCCATTTGAAAATGGACACCGGCATGGGACGGCTTGGAGTGAAAGAC GAGGAAGAGACGAAACGAATCGTAGCGCTGATTGAGCGCCATCCGCATTTTGTGCTTGAA GGGTTGTACACGCATTTTGCGACTGCGGATGAGGTGAACACCGATTATTTTTCCTATCAG TATACCCGTTTTTTGCACATGCTCGAATGGCTGCCGTCGCGCCCGCCGCTCGTCCATTGC GCCAACAGCGCAGCGTCGCTCCGTTTCCCTGACCGGACGTTCAATATGGTCCGCTTCGGC ATTGCCATGTATGGGCTTGCCCCGTCGCCCGGCATCAAGCCGCTGCTGCCGTATCCATTA AAAGAAGCATTTTCGCTCCATAGCCGCCTCGTACACGTCAAAAAACTGCAACCAGGCGAA AAGGTGAGCTATGGTGCGACGTACACTGCGCAGACGGAGGAGTGGATCGGGACGATTCCG ATCGGCTATGCGGACGGCGTCCGCCGCCTGCAGCACTTTCATGTCCTTGTTGACGGACAA AAGGCGCCGATTGTCGGCCGCATTTGCATGGACCAGTGCATGATCCGCCTGCCTGGTCCG CTGCCGGTCGGCACGAAGGTGACACTGATTGGTCGCCAAGGGGACGAGGTAATTTCCATT GATGATGTCGCTCGCCATTTGGAAACGATCAACTACGAAGTGCCTTGCACGATCAGTTAT CGAGTGCCCCGTATTTTTTTCCGCCATAAGCGTATAATGGAAGTGAGAAACGCCATTGGC CGCGGGGAAAGCAGTGCATAA PF00842 Ala_racemase_C PF01168 Ala_racemase_N function vitamin binding function pyridoxal phosphate binding function isomerase activity function racemase and epimerase activity function binding function racemase and epimerase activity, acting on amino acids and derivatives function alanine racemase activity function catalytic activity process amino acid and derivative metabolism process physiological process process pyruvate family amino acid metabolism process metabolism process alanine metabolism process cellular metabolism process amino acid metabolism BE0001194 Fatty acid-binding protein, adipocyte Human # Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284 # Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423 # Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/10592235 unknown Fatty acid-binding protein, adipocyte Involved in factty acid binding Lipid transport protein in adipocytes. Binds both long chain fatty acid and retinoic acid FABP4 8q21 Cytoplasm (Potential) None 7.25 14719.0 Human HUGO Gene Nomenclature Committee (HGNC) HGNC:3559 GenAtlas FABP4 GeneCards FABP4 GenBank Gene Database J02874 GenBank Protein Database 178347 UniProtKB P15090 UniProt Accession FABP4_HUMAN A-FABP Adipocyte lipid-binding protein AFABP ALBP >Fatty acid-binding protein, adipocyte MCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKN TEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVM KGVTSTRVYERA >399 bp ATGTGTGATGCTTTTGTAGGTACCTGGAAACTTGTCTCCAGTGAAAACTTTGATGATTAT ATGAAAGAAGTAGGAGTGGGCTTTGCCACCAGGAAAGTGGCTGGCATGGCCAAACCTAAC ATGATCATCAGTGTGAATGGGGATGTGATCACCATTAAATCTGAAAGTACCTTTAAAAAT ACTGAGATTTCCTTCATACTGGGCCAGGAATTTGACGAAGTCACTGCAGATGACAGGAAA GTCAAGAGCACCATAACCTTAGATGGGGGTGTCCTGGTACATGTGCAGAAATGGGATGGA AAATCAACCACCATAAAGAGAAAACGAGAGGATGATAAACTGGTGGTGGAATGCGTCATG AAAGGCGTCACTTCCACGAGAGTTTATGAGAGAGCATAA PF00061 Lipocalin function lipid binding function binding process cellular physiological process process transport process physiological process "

owl:sameAs

drug:Biotin

owl:sameAs

drug:Malonyl-Coenzyme A

rdf:type

drugbank:drugs

Local view for "http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/DB03766"

Context graph